Immuno Oncology (I-O) Market Size, Trends, Industry Analysis 
                      Immuno Oncology Io Market
Set to Exceed USD 38.89 billion by 2025 | CAGR 21.8%
“Immuno Oncology (I-O) Market Size, Trends, 
Industry Analysis By Treatment Approaches 
(Monoclonal Antibodies, Therapeutic Vaccines, 
Checkpoint Inhibitors, and Cytokines); By Novel 
Targets (IDO1i, LAG-3 CPI, oncolytic virus, STING 
agonist, TLR agonist, HDACi, TIL, VEGFi, MEKi, TIGIT, 
CPI, GITR agonist, TGF-b trap, and A2AR 
antagonist/CD73i); By Tumor Types; By Region: 
Market Size & Forecast, 2020 – 2025”
Immuno Oncology Io Market Estimate & Forecast to 2025
The global immuno-oncology market size is expected to reach USD 38.89 billion by 2025 
according to a new study by Polaris Market Research.
Immuno-oncology, also called as cancer immunotherapy is a biologic treatment, which 
enhances the body’s natural defenses to stop the growth of cancer. This therapy uses 
constituents made by the body or in a research laboratory to improve or reestablish the 
immune system function.
Immuno-oncology represents an innovative approach to cancer research that seeks to 
harness the body’s own immune system to fight tumor cells. Currently, world is at the 
forefront of this science with several compounds in development that are being investigated 
for use in a variety of cancers, as well as an approved immuno-oncology medicine that 
continues to be studied for new uses. The more precise targeting of patients for selected 
therapies is another important area of focus in oncology. Clinical biomarkers and 
pharmacogenomic studies are increasingly used to identify groups and sub-groups of 
patients most likely to benefit from an investigational agent in order to maximize its 
potential benefits.
Copyright © Polaris Market Research & Consulting LLP 2018. All Rights Reserved 2
                                                                            Request for sample
 Immuno Oncology Io Market Scope
By Treatment Approaches By Novel Targets By Tumor Types By Region Report Attributes
 Monoclonal Antibodies  IDO1i  Melanoma  North America  Historic year: 2015-2018
 Therapeutic Vaccines  LAG-3 CPI  Non-Small Cell Lung  Europe  Base year: 2019
 Checkpoint Inhibitors  Oncolytic virus Cancer  Asia Pacific  Forecast Year: 2020-2025
 Cytokines  STING agonist  Renal Cell Carcinoma  Latin America Middle  Revenue (USD Million)
 TLR agonist  Head & Neck Cancer East & Africa 
 HDACi  Bladder Cancer
 TIL  Classical Hodgkin’s 
 VEGFi Lymphoma
 MEKi  Merkel Cell Carcinoma
 TIGIT  Others
 CPI
 GITR agonist
 TGF-b trap
 A2AR antCaogpoynrigishtt/ C© DP7ol3ariis Market Research & Consulting LLP 2018. All Rights Reserved 3
Immuno Oncology Io Market Estimate & Forecast to 2025
On the basis of geography, North America was the largest regional market in 2019. High 
levels of spending on cancer treatments, also U.S. being one of the major country y with a 
huge population of cancer affected people on a global scale, the country being the host to 
the development of this technology, higher frequency of innovations of immuno oncology 
treatments or processes in the region specially in the U.S. etc., all of these factors have 
driven significant investment and alongside the demand for IO in the region. These factors 
have driven the North American market since the inception of this technology and over the 
forecast period it is expected to increase further.
Some of the key players operating in global immuno-oncology market are Bristol Myers 
Squibb, Merck, AstraZeneca, Roche Holding AG, Pfizer Inc., and Incyte Corporation among 
others.                                                                          
                                                                    
                                                                         
Copyright © Polaris Market Research & Consulting LLP 2018. All Rights Reserved 4
                                                                           Browse Complete Report
Immuno Oncology Io Market Share
Request for TOC
Copyright © Polaris Market Research & Consulting LLP 2018. All Rights Reserved 5
Immuno Oncology Io Market Study – Engagement Options
Buy Now – Click Here!
Buy now & have immediate access to premium insights
Purchase Report Sections – Click Here!
Regional analysis
Segmentation analysis
 Industry outlook
Competitive landscape
Speak To Analyst – Click Here!
Get your doubts clear
Schedule a call with our analyst before making any decision
Request For Sample Pages – Click Here!
Get free sample pages 
Understand report structure
Unmask data for validation
Copyright © Polaris Market Research & Consulting LLP 2018. All Rights Reserved 6
About Us
Polaris Market Research is a global market research and consulting company. The company 
specializes in providing exceptional market intelligence and in-depth business research services 
for our clientele spread across different enterprises. We at Polaris are obliged to e present across 
the industries of healthcare, technology, semi-conductors and chemicals among various other 
industries present around the world. 
We strive to provide our customers with updated information on innovative technologies, high 
growth markets, emerging business environments and latest business-centric applications, 
thereby helping them always to make informed decisions and leverage new opportunities. Adept 
with a highly competent, experienced and extremely qualified team of experts comprising SMEs, 
analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our 
customers.
 
Web: www.polarismarketresearch.com
Official Blog: http://polarismarketresearch.blogspot.com
Copyright © Polaris Market Research & Consulting LLP 2018. All Rights Reserved 7
Thank You!
Contact Us :
Polaris Market Research
30 Wall Street
8th Floor, 
New York City, NY 10005,
United States
E mail Id: [email protected]
Phone: +1-646-568-9980